Intelligence · Patents
Patents expiring in 2043
Annual patent cliff calendar for 2043 — US pharmaceutical patents by expiration date.
- Patents
- 1,718
Quick answer
1,718 indexed pharmaceutical patents have expiration dates in 2043. Browse by soonest expiry with links to assignee companies and related drugs.
-
KR 20230116805
가도테리돌 제조를 위한 제조 방법
granted -
US 11718589
Compositions and methods of modulating short-chain dehydrogenase
granted -
US 11718647
Virus-like particles and methods of use
granted -
US 11718665
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
granted -
US 11717553
Combined plant extract for getting rid of mites and acne and preparation method and use thereof
granted -
US 11718612
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11717573
Methods and compositions for the treatment of cancer
granted -
US 11717547
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 11718610
Compounds containing benzosultam
granted -
US 11717480
Extracellular vesicles and methods and uses thereof
granted -
US 11717576
Antibody-immune agonist conjugate and applications thereof
granted -
US 11718616
JAK kinase inhibitor compounds for treatment of respiratory disease
granted -
US 11718655
Masked interleukin-12 polypeptides
granted -
US 11718852
Non-liposomal systems for nucleic acid delivery
granted -
US 11718834
Compositions and methods for producing recombinant AAV
granted -
US 11718679
CD137 antibodies and PD-1 antagonists and uses thereof
granted -
US 11718658
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof
granted -
US 11718621
Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
granted -
US 11718613
N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitors
granted -
US 11718630
Compositions and methods for treating cancer
granted -
US 11718641
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted -
US 11718618
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
granted -
US 11718591
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
granted -
US 11717565
Recombinant BCG overexpressing phoP-phoR
granted -
US 11717542
Using tumor-navigating Salmonella to modulate tumor metabolism
granted -
US 11717558
Nucleic acid molecules encoding activin receptor type IIA variants
granted -
US 11718596
Amyloid targeting agents and methods of using the same
granted -
US 11718530
Allotrope of carbon having increased electron delocalization
granted -
US 11718576
Compositions and methods comprising resveratrol
granted -
CA 3235923
PROCEDES DE SYNTHESE A GRANDE ECHELLE DE COMPLEXES DE RADIONUCLEIDES
granted -
US 11725008
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11723635
Devices and methods for umbilical cord processing
granted -
US 11725207
Serpina1 iRNA compositions and methods of use thereof
granted -
US 11723961
Maspin, maspin derivatives, and maspin mimetics for reducing ROS, inflammation, and skin aging
granted -
US 11723362
Broad-spectrum synergistic antimicrobial compositions
granted -
US 11725209
TMPRSS6 iRNA compositions and methods of use thereof
granted -
US 11723929
Methods of improving cell-based therapy
granted -
US 11723864
Antimicrobial and anti-inflammatory compositions
granted -
US 11725208
Conjugated antisense compounds and their use
granted -
US 11723762
LIDAR based 3-D imaging with far-field illumination overlap
granted -
US 11725217
Methods to enhance myocardial regeneration and/or repair
granted -
US 11725060
Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods
granted -
US 11723885
Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
granted -
US 11723881
Fortified CBD oil for treatment of PTSD
granted -
US 11723946
Methods for regulating transcription of multiple genes and expression of multiple targets
granted -
US 11723900
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted -
US 11723959
Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide
granted -
US 11723980
IRAK degraders and uses thereof
granted
Frequently asked questions
How many pharma patents expire in 2043?
1,718 published patents in our USPTO index have expiration dates falling in calendar year 2043.